ACTIVE

Apotheek Daenen

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result66,7 k €+159,4 %over 1 year

Gross margin261,2 k €+27,6 %over 1 year

Equity359,1 k €+22,8 %over 1 year

Workforce1,8 ETP-18,2 %over 1 year

Identity

Source · BCE/KBO

Apotheek Daenen is a Public limited company incorporated in 1997. Its registered office is in Rotselaar. It employs on average 1,8 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0462.332.187
Incorporation: 31/12/1997
Legal form: Public limited company
Registered office: Stationsstraat 19
3110 Rotselaar · FlandreSee on map
Contributed capital: 61 973,38 €
Latest accounts: 31/12/2025
Average workforce: 1,8 ETP

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 19 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	261,2 k €	+27.6%	204,7 k €	-7.7%	221,8 k €	+1.2%	219,1 k €	-5.2%	231,1 k €
EBITDA	68,4 k €	+165%	-105,7 k €	-194%	112,5 k €	-6.7%	120,7 k €	+63.5%	73,8 k €
Operating result	66 k €	+160%	-109,3 k €	-203%	105,8 k €	-8.2%	115,3 k €	+68.2%	68,5 k €
Net result	66,7 k €	+159%	-112,3 k €	-220%	93,9 k €	-7.0%	101 k €	+141%	41,9 k €
Balance sheet
Equity	359,1 k €	+22.8%	292,4 k €	-27.7%	404,7 k €	+10.6%	365,8 k €	+10.9%	329,8 k €
Total assets	822,7 k €	+3.4%	795,6 k €	+13.9%	698,3 k €	+1.4%	688,6 k €	+6.1%	649,2 k €
Cash	6 k €	-49.4%	11,8 k €	-83.4%	71,2 k €	+10.2%	64,6 k €	-36.2%	101,3 k €
Debts	459,1 k €	-7.9%	498,5 k €	+73.6%	287,2 k €	-9.7%	317,9 k €	-0.2%	318,5 k €
Other
Workforce	1,8 ETP	-18.2%	2,2 ETP	+57.1%	1,4 ETP	+7.7%	1,3 ETP	-7.1%	1,4 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 18 ended

Active mandates

PharmaSci

Director · 0636.973.759

Represented by Kristien Daenen

Active

Ended mandates

PharmaSci

Managing director · since 29 décembre 2023 · 0636.973.759

Represented by Kristien DAENEN

Ended

Erik Daenen

Director · since 24 novembre 2021 · until 29 décembre 2023

Ended

Erik Daenen

Director · since 24 novembre 2021 · until 24 novembre 2027

Ended

PharmaSci

Managing director · since 24 novembre 2021 · until 24 novembre 2027 · 0636.973.759

Represented by Kristien Daenen

Ended

Other companies at this address

Stationsstraat 19 3110 Rotselaar

Company	CBE no.
Apotheek RC● Active	0777.659.490
PharmaSci● Active	0636.973.759
RC APOTHEEK● Active	1025.603.368

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/07/2023	01/07/2022	01/07/2021	01/07/2020	01/07/2019
Closing of the financial year	31/12/2025	31/12/2024	30/06/2023	30/06/2022	30/06/2021	30/06/2020
Length of the financial year	12 months	18 months	12 months	12 months	12 months	12 months
Filing date	21/08/2026	29/08/2025	23/01/2024	31/01/2023	02/02/2022	29/01/2021
General meeting	23/05/2026	24/05/2025	22/11/2023	23/11/2022	24/11/2021	16/12/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	23/05/2026	21/08/2026	Dutch	PDF
Abridged model	31/12/2024	24/05/2025	29/08/2025	Dutch	PDF
Abridged model	30/06/2023	22/11/2023	23/01/2024	Dutch	PDF
Abridged model	30/06/2022	23/11/2022	31/01/2023	Dutch	PDF
Abridged model	30/06/2021	24/11/2021	02/02/2022	Dutch	PDF
Abridged model	30/06/2020	16/12/2020	29/01/2021	Dutch	PDF
Abridged model	30/06/2019	18/12/2019	03/02/2020	Dutch	PDF
Abridged model	30/06/2018	19/12/2018	15/01/2019	Dutch	PDF
Abridged model	30/06/2017	13/12/2017	12/01/2018	Dutch	PDF
Abridged model	30/06/2016	23/11/2016	23/02/2017	Dutch	PDF
Abridged model	30/06/2015	25/11/2015	25/02/2016	Dutch	PDF
Abridged model	30/06/2014	26/11/2014	18/12/2014	Dutch	PDF
Abridged model	30/06/2013	18/12/2013	20/02/2014	Dutch	PDF
Abridged model	30/06/2012	19/12/2012	21/02/2013	Dutch	PDF
Abridged model	30/06/2011	14/12/2011	23/02/2012	Dutch	PDF
Abridged model	30/06/2010	15/12/2010	28/03/2011	Dutch	PDF
Abridged model	30/06/2009	16/12/2009	19/01/2010	Dutch	PDF
Abridged model	30/06/2008	17/12/2008	23/01/2009	Dutch	PDF
Abridged model	30/06/2007	19/12/2007	28/01/2008	Dutch	PDF
Abridged model	30/06/2006	13/12/2006	29/01/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 18 ended

Active mandates

PharmaSci

Director · 0636.973.759

Represented by Kristien Daenen

Active

Ended mandates

PharmaSci

Managing director · since 29 décembre 2023 · 0636.973.759

Represented by Kristien DAENEN

Ended

Erik Daenen

Director · since 24 novembre 2021 · until 29 décembre 2023

Ended

Erik Daenen

Director · since 24 novembre 2021 · until 24 novembre 2027

Ended

PharmaSci

Managing director · since 24 novembre 2021 · until 24 novembre 2027 · 0636.973.759

Represented by Kristien Daenen

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates25/01/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - MAATSCHAPPELIJKE ZETEL - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - BOEKJAAR
PDF
Mandates16/03/2022
ONTSLAGEN - BENOEMINGEN
PDF
Mandates18/02/2020
ONTSLAGEN - BENOEMINGEN
PDF
Mandates16/02/2016
ONTSLAGEN - BENOEMINGEN
PDF
Mandates21/10/2015
BENAMING - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates21/08/2014
ONTSLAGEN - BENOEMINGEN
PDF
Mandates05/01/2012
ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates27/10/2005
KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 202566,7 k €↑
2024
Annual accounts 2024-112,3 k €↓
2023
Annual accounts 202393,9 k €↓
2022
Annual accounts 2022101 k €↑
2021
Annual accounts 202141,9 k €↓
2020
Annual accounts 202099,3 k €↑
2019
Annual accounts 201977,8 k €↑
2018
Annual accounts 201865,6 k €↑
2017
Annual accounts 201762,2 k €↑
2016
Annual accounts 2016-71,2 k €↓
2015
Annual accounts 201541,9 k €↑
2014
Annual accounts 201431,3 k €↓
2013
Annual accounts 201336,4 k €↑
2012
Annual accounts 201220,8 k €↓
2011
Annual accounts 201125,6 k €↓
2010
Annual accounts 201037,3 k €↑
2009
Annual accounts 200936,5 k €↓
2008
Annual accounts 200867 k €↑
2007
Annual accounts 200726 k €
31/12/1997
IncorporationPublic limited company

Apotheek Daenen

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline